June 17th 2021, 4:00pm
By Ann Pinyan
A woman with stage 4 ovarian cancer discusses the importance of having compassion for other people, because you never know what they may be dealing with.
June 17th 2021, 3:00pm
By Jamie Cesanek
In this episode of the “CURE® Talks Cancer” podcast, Colin Jackson explains how he was able to complete a marathon even after cancer treatments that called for surgical removal of part of his femur, hip and surrounding muscle.
June 17th 2021, 1:00pm
By Antonia DePace
Novel combo regimen reduces number of toxic treatments in patients with NSCLC.
June 16th 2021, 9:00pm
By Darlene Dobkowski, MA
The combination of Imbruvica with Venclexta significantly reduced the risk for progression or death by 78% compared with chlorambucil plus obinutuzumab.
June 16th 2021, 6:00pm
In an interview with CURE®, a survivor recounts how his experiences with cancer treatment in the 1960s, when he was treated in a segregated “colored” ward, have led him to a life of advocacy work.
June 16th 2021, 4:00pm
By Felicia Mitchell
“Hiking is a great activity for all of us, including cancer survivors,” writes a breast cancer survivor. “As long as we can put one foot in front of the other, being out on a trail is inspirational and health-affirming.”
June 16th 2021, 3:21pm
Common questions asked by patients with lung or thyroid cancer who have been referred for biomarker testing and advice for setting expectations from test results.
June 16th 2021, 3:15pm
Drs Benjamin Levy and Lori J. Wirth comment on the current role of liquid biopsies in lung and thyroid cancer.
June 16th 2021, 3:00pm
By Arlene Weintraub
BiTE therapy could lead to better ways to target the immune system, while minimizing the chance of resistance.
June 16th 2021, 1:00pm
Reaching a younger age group of African American men for prostate cancer detection may improve their survival outcomes, says an expert from the University of California San Diego.
June 15th 2021, 9:00pm
By Sara Karlovitch
Treatment with the combination of Stivarga and Bavencio was associated with minor anti-tumor activity in patients with advanced, heavily pretreated biliary tract solid tumors.
June 15th 2021, 6:00pm
By Shari Mycek
Treatment with pyrotinib and the chemotherapies trastuzumab, docetaxel and carboplatin significantly improved response rates over the triplet chemotherapy regimen alone in the neoadjuvant treatment of patients with HER2-positive breast cancer.
June 15th 2021, 4:00pm
By Jane Biehl Ph.D.
A cancer survivor describes how oncology nurses have had a deep impact on her during treatment.
June 15th 2021, 3:00pm
By Amy Patural, M.S., M.P.H.
First immunotherapy, intralesional therapy, is making a comeback and producing durable remissions for a subgroup of patients with cancer.
June 15th 2021, 1:00pm
Experts urge patients to stop playing the wait-and-see game: There’s no ‘playbook’ for immunotherapy-related toxicities, and side effects can be managed if caught early.
Registration for Move4Her is Now Open!
Standing Firm Against the Financial Burden of Cancer
Sunscreen 101: How to Get the Most out of Your Sun Protection Products
Spotlight: Marissa Willis, Patient & Caregiver Advisory Council
